Insulet | Omløpsmidler



Current Assets Endring Dato
Abbott USD 23.66B 146M 2024-12
Align Technology USD 2.49B 104.95M 2024-12
AtriCure USD 267.83M 1.46M 2024-12
Avanos Medical USD 393.4M 79.2M 2024-12
Baxter International USD 8.85B 11M 2024-12
Becton, Dickinson and Co. USD 8.66B 1.81B 2024-12
Boston Scientific USD 6.92B 1.84B 2024-12
Cardinal Health USD 35.76B 2.85B 2024-12
Cooper Companies USD 1.99B 35.5M 2025-01
Dexcom USD 4.3B 38.6M 2024-12
Edwards Lifesciences USD 6.29B 442.3M 2024-12
Eli Lilly USD 32.74B 1.32B 2024-12
Globus Medical USD 2.18B 120.73M 2024-12
ICU Medical USD 1.44B 183.93M 2024-12
Insulet USD 1.89B 30.4M 2024-12
Integra LifeSciences USD 1.08B 17.84M 2024-12
J&J USD 55.89B 2.64B 2024-12
Masimo USD 1.23B 54.1M 2024-12
Medtronic USD 22.51B 75M 2025-01
Merit Medical Systems USD 923.77M 154.54M 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Solventum Corp 3.25B 105M 2024-12
Stryker USD 14.85B 174M 2024-12
Tandem Diabetes Care USD 724.49M 28.33M 2024-12
Teleflex USD 1.47B 28.18M 2024-12
West Pharmaceutical Services USD 1.54B 12.5M 2024-12
Zimmer Biomet Holdings USD 4.67B 192.5M 2024-12



Insulet Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.